Berodual solution for inhalation 20 ml — Made in Germany — Free Delivery

Indications

Prevention and symptomatic treatment of chronic obstructive airway disorders: allergic and non-allergic (endogenous) bronchial asthma; exercise-induced asthma; and chronic obstructive bronchitis with and without emphysema.

With prolonged therapy, it is necessary to prescribe concomitant anti-inflammatory therapy.

Contraindications

Hypersensitivity to fenoterol hydrobromide, atropine-like substances or other components of the preparation; hypertrophic obstructive cardiomyopathy, tachyarrhythmia.

Compound

active ingredients: ipratropium bromide, fenoterol hydrobromide; 1 ml (20 drops) solution for inhalation contains ipratropium bromide 261 mcg, which is equivalent to 250 mcg and anhydrous pratropium bromide; fenoterol hydrobromide 500 mcg; other components: benzalkonium chloride, disodium edetate, sodium chloride, concentrated hydrochloric acid, purified water.

Dosage and administration

Only for inhalation with a nebulizer.

Treatment should be started and carried out under the supervision of a physician, for example, in a hospital setting.

Home treatment, after consultation with an experienced physician, may be recommended for patients in whom the use of low-dose fast-acting beta-agonists, such as Berodual N, metered-dose aerosol, was insufficient to relieve the condition. Home treatment may also be recommended for patients who need to use a nebulizer for other reasons (eg, problems with aerosols). Or because of the need to obtain higher doses for patients who know the rules for using a nebulizer. Therapy should begin with the lowest recommended dose.

The dose should be selected individually depending on the severity of the acute episode.

Use should be stopped when symptom relief is achieved.

The solution for inhalation is intended only for inhalation using an appropriate nebulizer and should not be taken orally.

For use, the recommended dose should be diluted with saline (0.9%) to a final volume of 3-4 ml. The diluted ready-to-use solution should be inhaled until sufficient relief of symptoms is achieved.

The diluted ready-to-use solution must be freshly prepared before use. Ready-to-use solution should be used immediately after preparation; any remaining diluted solution must be destroyed. Patients should follow the nebulizer manufacturer's instructions.

It is recommended to inhale a spray solution intended for use with a nebulizer through the mouthpiece. In the absence of a mouthpiece, a mask that fits snugly to the face should be used. Patients with a predisposition to the development of glaucoma should take special care to protect their eyes.

BERODUAL inhalation solution can be used with various models of nebulizers. The total dose and the dose reaching the lungs depends on the nebulizer used and may be higher than with BERODUAL N aerosol, depending on the effectiveness of the device.

Recommended dosage regimens

Adults and children from 12 years old.

Emergency treatment of sudden attacks of bronchospasm.

Depending on the severity of an acute attack, 1.0-2.5 ml of BERODUAL is used after dilution with saline to a volume of 3-4 ml.

In extremely severe cases, up to 4 ml of BERODUAL can be used after dilution with saline to a volume of 3-4 ml.

For the prevention of exercise-induced asthma or suspected allergic contact, 0.1-0.2 ml of BERODUAL diluted with 2-3 ml of saline is used, if possible, 10-15 minutes before the incident.

Children aged 6 - 12 years.

Emergency treatment of acute asthma attacks.

Depending on the severity of the acute attack and the age of the patient, 0.5-2.0 ml of BERODUAL is used after dilution with saline to a volume of 3-4 ml.

For the prevention of exercise-induced asthma or suspected allergic contact, 0.1-0.2 ml of BERODUAL diluted with 2-3 ml of saline is used, if possible, 10-15 minutes before the incident.

Children under 6 years of age (weighing less than 22 kg).

Considering that information on the use of the preparation in this age group is limited, it is recommended to use the preparation in the dose indicated below only under medical supervision of the patient's condition:

• 0.1 ml per 1 kg of body weight (up to a maximum of 0.5 ml) per dose after diluting with saline to a volume of 3-4 ml.
• BERODUAL solution for inhalation must not be diluted with distilled water.
• BERODUAL is suitable for concomitant inhalation with Lazolvan, a solution for inhalation and oral administration.

Children.

Berodual is used in pediatric practice. For children under 6 years of age, the preparation  is prescribed only under the condition of medical supervision of the patient's condition.